233 related articles for article (PubMed ID: 25785733)
1. Antimicrobial Activity of Plectasin NZ2114 in Combination with Cell Wall Targeting Antibiotics Against VanA-Type Enterococcus faecalis.
Breidenstein EB; Courvalin P; Meziane-Cherif D
Microb Drug Resist; 2015 Aug; 21(4):373-9. PubMed ID: 25785733
[TBL] [Abstract][Full Text] [Related]
2. Time-kill study and synergistic activity of cell-wall inhibitor antibiotics in combination with gentamicin against Enterococcus faecalis and Enterococcus faecium.
Aligholi M; Emaneini M; Taherikalani M; Shahsavan S; Jabalameli F; Asadollahi P; Khoramian B; Eslampour MA
Acta Microbiol Immunol Hung; 2011 Sep; 58(3):219-26. PubMed ID: 21983323
[TBL] [Abstract][Full Text] [Related]
3. Induction of VanA vancomycin resistance genes in Enterococcus faecalis: use of a promoter fusion to evaluate glycopeptide and nonglycopeptide induction signals.
Grissom-Arnold J; Alborn WE; Nicas TI; Jaskunas SR
Microb Drug Resist; 1997; 3(1):53-64. PubMed ID: 9109096
[TBL] [Abstract][Full Text] [Related]
4. Dalbavancin activity against selected populations of antimicrobial-resistant Gram-positive pathogens.
Streit JM; Sader HS; Fritsche TR; Jones RN
Diagn Microbiol Infect Dis; 2005 Dec; 53(4):307-10. PubMed ID: 15922534
[TBL] [Abstract][Full Text] [Related]
5. In vitro efficacy of fosfomycin-based combinations against clinical vancomycin-resistant Enterococcus isolates.
Tang HJ; Chen CC; Zhang CC; Su BA; Li CM; Weng TC; Chiang SR; Ko WC; Chuang YC
Diagn Microbiol Infect Dis; 2013 Nov; 77(3):254-7. PubMed ID: 24029433
[TBL] [Abstract][Full Text] [Related]
6. Heterologous expression of glycopeptide resistance vanHAX gene clusters from soil bacteria in Enterococcus faecalis.
Hasman H; Aarestrup FM; Dalsgaard A; Guardabassi L
J Antimicrob Chemother; 2006 Apr; 57(4):648-53. PubMed ID: 16476725
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic activity against urinary tract infection (UTI) isolates of vancomycin-resistant enterococci (VRE): results from the 2002 North American Vancomycin Resistant Enterococci Susceptibility Study (NAVRESS).
Zhanel GG; Laing NM; Nichol KA; Palatnick LP; Noreddin A; Hisanaga T; Johnson JL; Hoban DJ;
J Antimicrob Chemother; 2003 Sep; 52(3):382-8. PubMed ID: 12888592
[TBL] [Abstract][Full Text] [Related]
8. Specificity of induction of the vanA and vanB operons in vancomycin-resistant enterococci by telavancin.
Hill CM; Krause KM; Lewis SR; Blais J; Benton BM; Mammen M; Humphrey PP; Kinana A; Janc JW
Antimicrob Agents Chemother; 2010 Jul; 54(7):2814-8. PubMed ID: 20404117
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the first clinical isolate of vancomycin-resistant Enterococcus faecalis, AH803, in Taiwan.
Lu JJ; Ben RJ; Perng CL; Chi WM; Chu ML; Lee WH
J Formos Med Assoc; 2000 Feb; 99(2):178-81. PubMed ID: 10770036
[TBL] [Abstract][Full Text] [Related]
10. Specificity of induction of glycopeptide resistance genes in Enterococcus faecalis.
Baptista M; Depardieu F; Courvalin P; Arthur M
Antimicrob Agents Chemother; 1996 Oct; 40(10):2291-5. PubMed ID: 8891132
[TBL] [Abstract][Full Text] [Related]
11. Different VanA Elements in E. faecalis and in E. faecium Suggest at Least Two Origins of Tn1546 Among VRE in a Brazilian Hospital.
Merlo TP; Dabul AN; Camargo IL
Microb Drug Resist; 2015 Jun; 21(3):320-8. PubMed ID: 25588068
[TBL] [Abstract][Full Text] [Related]
12. Genotypic characterization of a nosocomial outbreak of VanA Enterococcus faecalis.
Biavasco F; Miele A; Vignaroli C; Manso E; Lupidi R; Varaldo PE
Microb Drug Resist; 1996; 2(2):231-7. PubMed ID: 9158765
[TBL] [Abstract][Full Text] [Related]
13. Restoration of vancomycin susceptibility in Enterococcus faecalis by antiresistance determinant gene transfer.
Torres Viera C; Tsiodras S; Gold HS; Coakley EP; Wennersten C; Eliopoulos GM; Moellering RC; Inouye RT
Antimicrob Agents Chemother; 2001 Mar; 45(3):973-5. PubMed ID: 11181395
[TBL] [Abstract][Full Text] [Related]
14. Vancomycin-resistant Enterococcus spp.: validation of susceptibility testing and in vitro activity of vancomycin, linezolid, tigecycline and daptomycin.
Rathe M; Kristensen L; Ellermann-Eriksen S; Thomsen MK; Schumacher H
APMIS; 2010 Jan; 118(1):66-73. PubMed ID: 20041873
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial resistance profiles of Enterococcus faecalis and Enterococcus faecium isolated from artisanal food of animal origin in Argentina.
Delpech G; Pourcel G; Schell C; De Luca M; Basualdo J; Bernstein J; Grenovero S; Sparo M
Foodborne Pathog Dis; 2012 Oct; 9(10):939-44. PubMed ID: 22953740
[TBL] [Abstract][Full Text] [Related]
16. Synergistic activity of vancomycin and teicoplanin alone and in combination with streptomycin against Enterococcus faecalis strains with various vancomycin susceptibilities.
Babalola CP; Patel KB; Nightingale CH; Nicolau DP
Int J Antimicrob Agents; 2004 Apr; 23(4):343-8. PubMed ID: 15081082
[TBL] [Abstract][Full Text] [Related]
17. Rapid detection and differentiation method of VanA, VanB and VanC phenotypes in vancomycin-resistant enterococci.
Hanaki H; Yamaguchi Y; Nomura S; Nagayama A; Sunakawa K
Int J Antimicrob Agents; 2004 May; 23(5):502-5. PubMed ID: 15120731
[TBL] [Abstract][Full Text] [Related]
18. Synergism between beta-lactams and glycopeptides against VanA-type methicillin-resistant Staphylococcus aureus and heterologous expression of the vanA operon.
Périchon B; Courvalin P
Antimicrob Agents Chemother; 2006 Nov; 50(11):3622-30. PubMed ID: 16954318
[TBL] [Abstract][Full Text] [Related]
19. PCR detection of the vanA gene in a vancomycin-resistant Enterococcus faecalis clinical isolate from Hungary.
Ghidán A; Jeney C; Maródi CL; Csiszár K; Rozgonyi F
J Antimicrob Chemother; 2000 Aug; 46(2):325-6. PubMed ID: 10933665
[No Abstract] [Full Text] [Related]
20. Clinical implications of vancomycin-resistant Enterococcus faecium (VRE) with VanD phenotype and vanA genotype.
Song JH; Ko KS; Suh JY; Oh WS; Kang CI; Chung DR; Peck KR; Lee NY; Lee WG
J Antimicrob Chemother; 2008 Apr; 61(4):838-44. PubMed ID: 18230690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
